Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04995094
Title Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors HiberCell, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093-0990 United States Details
Innovative Clinical Research Institute Whittier California 90603 United States Details
Ichan School of Medicine at Mount Sinai New York New York 10029 United States Details
Allegheny Health Network Pittsburgh Pennsylvania 15212 United States Details
*Shaded cells indicate that there was no data available from for the field